Retinoic acid in gut immune homestatis and infection
Retinoic acid in gut immune homestatis and infection
批准号:
9205215
负责人:
RANDOLPH J. NOELLE
金额:
$59.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-01-15 至 2019-12-31
关键词:
AblationAddressAntigensArchitectureAreaAutoimmunityBackBacteriaBindingBiologicalCD8-Positive T-LymphocytesCD8B1 geneCell Differentiation processCell LineageCell SurvivalCellsCellular biologyCommunicable DiseasesDataDevelopmentDiseaseDisease modelDominant-Negative MutationEmployee StrikesEnhancersEquilibriumEragrostisEventFOXP3 geneFunctional disorderGenesGenetic ModelsGraft RejectionHematopoieticHost resistanceIL17 geneImmuneImmune responseImmunityImmunizationImpairmentIn VitroInfectionInfiltrationInflammatoryInflammatory Bowel DiseasesLeukocytesListeria monocytogenesLiteratureMaintenanceMemoryMolecularMonitorMucosal ImmunityMusOralPathogenicityPathway interactionsPhenotypePredispositionPreschool ChildProtein IsoformsPublishingRegulationRegulatory T-LymphocyteReportingRepressionResistanceRoleSTAT4 geneSignal TransductionSpecific qualifier valueSupporting CellSyndromeSystemic infectionT-LymphocyteTh1 CellsTimeTissuesTretinoinVitamin AWorkadaptive immune responsecomparativegenetic approachimprovedin vivomucosal sitenovelnovel therapeuticsoral infectionoverexpressionpathogenpreventprogramspublic health relevancereceptorresponseretinoic acid receptor alphatranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose that retinoic acid (RA) regulates mucosal adaptive immune response controlling the fate of committed (Th1, Treg, CD8eff) T cells. In the absence of RA signaling, we show that RA, through its receptor RARα, sustains stable expression of Th1 lineage specifying genes as well as repressing genes that instruct Th17 cell fate. Our studies identify RA-RARα as a key component of the regulatory network governing Th1 cell fate and define a new paradigm of Th1aTh17 differentiation. These findings have important implications for gut immunity in which dysregulated Th1-Th17 responses are observed. We further show that ablation of RA signaling in the Foxp3 lineage ablates in vivo Treg function. Finally, impairment of RA signaling of through specific receptor isoforms limits CD8 T cell survival and differentiation. As such, we propose that these functions of RA are prominent in its role in host resistance to infectious disease. Using genetic models that allow lineage specific control of RA signaling in vivo we will: 1. Define the role of RA in Th1 stability
and repression of Th1aTh17 differentiation in the gut in vivo. We show that RA controls the level of T-bet expression in Th1 T cells and as such controls Th1 lineage maintenance. Furthermore, we show that T cells which are deprived of an RA signal develop into double positive, IL17+, IFNgLow T cells and Th17 cells. RARa CHIPseq studies and transcriptome analysis have identified for the first time, direct targets for RAR regulation in T cells and provie important biological leads as to how RA programs T cell lineage maintenance and phenotype. Finally, given the fact that RA tissue levels control critical events in T cell commitment, we will
exploit the use of genetic models where RA synthesis can be specifically ablated in the lineage of choice to determine the RA-synthesizing cells that support T cell fate in vivo. 2. Define the role of RA in sustaining Treg function in the gut. Selective silencing of RA signaling in the Foxp3
lineage, results in the emergence of a striking inflammatory syndrome that we hypothesize is due to Treg lineage instability and dysfunction. It is proposed that both natural and adaptive Treg function is ablated and the underlying cellular and molecular mechanisms will be addressed. 3. Understanding the role of RA in CD8 lineage commitment in the gut. We have defined specific distinctive contributions of RARa vs RARb in CD8 T cell biology. In CD8+ T cells, RARa is critical for T cell survival and RARb is critical for antigen-specific T cell expansion. These approaches provide the novel and exciting opportunity to fully define the role of RAR isoforms in CD8+ T cell stability, survival, expansion and development of memory. A comprehensive set of studies is presented which will represent the first to track and quantify the antigen-specific CD8+ T cell responses in the gut.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
-
批准号:10170281
-
项目类别:
-
资助金额:$57.0万
-
财政年份:2017
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
-
批准号:9917740
-
项目类别:
-
资助金额:$57.0万
-
财政年份:2017
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Retinoic acid in gut immune homestatis and infection
-
批准号:8913568
-
项目类别:
-
资助金额:$60.98万
-
财政年份:2015
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
VISTA, a novel regulator of immunity and autoimmunity
-
批准号:8840881
-
项目类别:
-
资助金额:$57.85万
-
财政年份:2012
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
VISTA, a novel regulator of immunity and autoimmunity
-
批准号:8463984
-
项目类别:
-
资助金额:$52.79万
-
财政年份:2012
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease
-
批准号:8314301
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2012
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease
-
批准号:8461514
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2012
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
VISTA, a novel regulator of immunity and autoimmunity
-
批准号:8387505
-
项目类别:
-
资助金额:$53.74万
-
财政年份:2012
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Safe and effective anti CD154 antibodies for therapeutic intervention
-
批准号:8523637
-
项目类别:
-
资助金额:$99.8万
-
财政年份:2012
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Safe And Effective Anti-CD154 Antibodies For Therapeutic Intervention
-
批准号:8394297
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2012
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
The Th17-IL-9 mast cell axis in inflammatory disease
-
批准号:8090444
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2010
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
The Th17-IL-9 mast cell axis in inflammatory disease
-
批准号:7895444
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2010
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Vitamin A and acquired immune privilege
-
批准号:8540340
-
项目类别:
-
资助金额:$48.05万
-
财政年份:2009
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
IMMUNOLOGY AND CANCER IMMUNOTHERAPY RESEARCH PROGRAM
-
批准号:7944611
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2009
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Synergy of the innate and acquired immune responses in tumor immunology
-
批准号:7942248
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2009
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Effector Mechanisms in Graft Tolerance
-
批准号:7922765
-
项目类别:
-
资助金额:$15.41万
-
财政年份:2009
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Vitamin A and acquired immune privilege
-
批准号:7907551
-
项目类别:
-
资助金额:$54.29万
-
财政年份:2009
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Vitamin A and acquired immune privilege
-
批准号:8309410
-
项目类别:
-
资助金额:$48.44万
-
财政年份:2009
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
Vitamin A and acquired immune privilege
-
批准号:8131884
-
项目类别:
-
资助金额:$48.15万
-
财政年份:2009
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
COBRE CORE D: INFORMATICS SUPPORT CORE
-
批准号:7959995
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2009
-
负责人:RANDOLPH J. NOELLE
-
依托单位:
海外基金